<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">28651405</PMID><DateCompleted><Year>2017</Year><Month>09</Month><Day>04</Day></DateCompleted><DateRevised><Year>2018</Year><Month>12</Month><Day>02</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0254-6450</ISSN><JournalIssue CitedMedium="Print"><Volume>38</Volume><Issue>5</Issue><PubDate><Year>2017</Year><Month>May</Month><Day>10</Day></PubDate></JournalIssue><Title>Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi</Title><ISOAbbreviation>Zhonghua Liu Xing Bing Xue Za Zhi</ISOAbbreviation></Journal><ArticleTitle>[Clinical stages and outcomes of severe cases on hand, foot and mouth disease].</ArticleTitle><Pagination><StartPage>651</StartPage><EndPage>655</EndPage><MedlinePgn>651-655</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3760/cma.j.issn.0254-6450.2017.05.019</ELocationID><Abstract><AbstractText><b>Objective:</b> To understand the characteristics and relation of clinical stage and outcome of severe cases on hand, foot and mouth disease (HFMD) and to establish the evaluation method for understanding severity of this disease. <b>Methods:</b> According to factors as geographical location, economic and epidemic levels, five provinces (Henan, Shandong, Yunnan, Zhejiang and Sichuan provinces) were selected. Reported severe cases of HFMD from the National Notifiable Diseases Reporting System were selected randomly in the five provinces. Basic epidemiological information, clinical data, and pathogen testing results in the involved hospitals were collected. Clinical stages on all the patients were decided in accordance with"the clinical expert consensus on diagnosis and treatment for severe case of enterovirus type 71 (EV71) infections (2011 edition)" . Data were analyzed using SPSS software 18.0 and other epidemiological methods. <b>Results:</b> A total of657 severe HFMD cases were investigated, with 326 cases positive of EV71, accounting for 91.3<i>%</i> (326/357) among all the laboratory-confirmed cases. Of the 657 cases, 542 cases (82.5<i>%</i>, 95<i>%CI</i>: 79.4<i>%-</i>85.3<i>%</i>) were diagnosed as in stage 2 (with nervous system involvement), 99 cases (15.1<i>%</i>, 95<i>%CI</i>: 12.4<i>%-</i>18.0<i>%</i>) in stage 3 (early phase of function failure on heart and lung), and 16 cases (2.4<i>%</i>, 95<i>%CI</i>: 1.4<i>%-</i>3.9<i>%</i>) were in stage 4 (function failure of heart and lung). 11 cases (1.7<i>%</i>, 95<i>%CI</i>: 0.9<i>%-</i>3.0<i>%</i>) were with squeal when discharged from hospital with 8 cases (1.2<i>%</i>, 95<i>%CI</i>: 0.6<i>%-</i>2.3<i>%</i>) died. When comparing the proportions among stage 2, stage 3 and stage 4, significant differences were found between age groups (<i>&#x3c7;</i>(2)=22.632, <i>P</i>=0.012). The younger the patient was the lower the proportions of stage 2 and the more proportion of stage 3 appeared. When comparing the proportions of clinical stages among the five provinces, significant differences (<i>&#x3c7;</i>(2)=41.481, <i>P</i>=0.000) were noticed. Proportions of different clinical stages in gender, ethnicity, occupation, place of residence types and the type of pathogen appeared no significant differences, respectively. However, the proportions of squeal and death in stage 2, stage 3 and stage 4 showed significant differences (sequela: <i>&#x3c7;</i>(2)=12.960, <i>P</i>=0.001; Death: <i>&#x3c7;</i>(2)=16.850, <i>P</i>=0.001), respectively. <b>Conclusions:</b> The percentage of clinical stages of severe HFMD patients related to the rate of squeal and death. Clinical staging can be used for assessing the clinical severity of complications and the effectiveness of treatment, of HFMD.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Division of Infectious Disease, Chinese Center for Disease Control and Prevention, Beijing 102206, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jin</LastName><ForeName>Y</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Division of Infectious Disease, Taizhou City Center for Disease Control and Prevention, Taizhou 318000, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>J L</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Division of Infectious Disease, Chinese Center for Disease Control and Prevention, Beijing 102206, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Y X</ForeName><Initials>YX</Initials><AffiliationInfo><Affiliation>Institute of Infectious Disease, Henan Provincial Center for Disease Control and Prevention, Zhengzhou 450016, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>X J</ForeName><Initials>XJ</Initials><AffiliationInfo><Affiliation>Institute of Viral Disease, Shandong Provincial Center for Disease Control and Prevention, Jinan 250014, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fu</LastName><ForeName>X Q</ForeName><Initials>XQ</Initials><AffiliationInfo><Affiliation>Institute of Infectious Disease, Yunnan Provincial Center for Disease Control and Prevention, Kunming 650022, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miao</LastName><ForeName>Z P</ForeName><Initials>ZP</Initials><AffiliationInfo><Affiliation>Institute of Infectious Disease, Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou 310051, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lyu</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Institute of Infectious Disease, Sichuan Provincial Center for Disease Control and Prevention, Chengdu 610041, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>chi</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>China</Country><MedlineTA>Zhonghua Liu Xing Bing Xue Za Zhi</MedlineTA><NlmUniqueID>8208604</NlmUniqueID><ISSNLinking>0254-6450</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002681" MajorTopicYN="N">China</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="Y">Enterovirus A, Human</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058872" MajorTopicYN="Y">Epidemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006232" MajorTopicYN="N">Hand, Foot and Mouth Disease</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006761" MajorTopicYN="N">Hospitals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012959" MajorTopicYN="N">Socioeconomic Factors</DescriptorName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="chi"><AbstractText><b>&#x76ee;&#x7684;&#xff1a;</b> &#x4e86;&#x89e3;&#x624b;&#x8db3;&#x53e3;&#x75c5;&#x91cd;&#x75c7;&#x75c5;&#x4f8b;&#x4e34;&#x5e8a;&#x5206;&#x671f;&#x4e0e;&#x7ed3;&#x5c40;&#x7684;&#x7279;&#x5f81;&#x53ca;&#x5173;&#x8054;&#x6027;&#xff0c;&#x4e3a;&#x5efa;&#x7acb;&#x4e34;&#x5e8a;&#x91cd;&#x75c7;&#x75c5;&#x4f8b;&#x8bc4;&#x4f30;&#x65b9;&#x6cd5;&#x63d0;&#x4f9b;&#x4f9d;&#x636e;&#x3002; <b>&#x65b9;&#x6cd5;&#xff1a;</b> &#x6839;&#x636e;&#x5730;&#x7406;&#x4f4d;&#x7f6e;&#x3001;&#x7ecf;&#x6d4e;&#x72b6;&#x51b5;&#x548c;&#x75ab;&#x60c5;&#x9ad8;&#x53d1;&#x6c34;&#x5e73;&#x9009;&#x62e9;&#x6cb3;&#x5357;&#x3001;&#x5c71;&#x4e1c;&#x3001;&#x6d59;&#x6c5f;&#x3001;&#x56db;&#x5ddd;&#x548c;&#x4e91;&#x5357;&#x7701;&#xff0c;&#x968f;&#x673a;&#x62bd;&#x53d6;&#x6cd5;&#x5b9a;&#x4f20;&#x67d3;&#x75c5;&#x62a5;&#x544a;&#x4e2d;&#x624b;&#x8db3;&#x53e3;&#x75c5;&#x91cd;&#x75c7;&#x75c5;&#x4f8b;&#xff0c;&#x6536;&#x96c6;&#x75c5;&#x4f8b;&#x4eba;&#x53e3;&#x5b66;&#x3001;&#x4e34;&#x5e8a;&#x8d44;&#x6599;&#x548c;&#x5b9e;&#x9a8c;&#x5ba4;&#x68c0;&#x6d4b;&#x7ed3;&#x679c;&#x7b49;&#xff0c;&#x6309;&#x7edf;&#x4e00;&#x6807;&#x51c6;&#x8fdb;&#x884c;&#x4e34;&#x5e8a;&#x5206;&#x671f;&#xff0c;&#x5206;&#x6790;&#x5404;&#x671f;&#x75c5;&#x4f8b;&#x6784;&#x6210;&#x3001;&#x4e34;&#x5e8a;&#x7ed3;&#x5c40;&#x53ca;&#x5176;&#x5173;&#x8054;&#x6027;&#x3002; <b>&#x7ed3;&#x679c;&#xff1a;</b> &#x5171;&#x8c03;&#x67e5;&#x624b;&#x8db3;&#x53e3;&#x75c5;&#x91cd;&#x75c7;&#x75c5;&#x4f8b;657&#x4f8b;&#x3002;&#x5b9e;&#x9a8c;&#x5ba4;&#x8bca;&#x65ad;&#x75c5;&#x4f8b;357&#x4f8b;&#xff0c;&#x5176;&#x4e2d;&#x80a0;&#x9053;&#x75c5;&#x6bd2;71&#x578b;&#x9633;&#x6027;&#x75c5;&#x4f8b;326&#x4f8b;&#xff0c;&#x5360;91.3<i>%</i>&#xff08;326/357&#xff09;&#x3002;&#x4e34;&#x5e8a;&#x5206;&#x671f;&#xff1a;2&#x671f;&#xff08;&#x795e;&#x7ecf;&#x7cfb;&#x7edf;&#x53d7;&#x7d2f;&#x671f;&#xff09;&#x75c5;&#x4f8b;542&#x4f8b;&#x3001;3&#x671f;&#xff08;&#x5fc3;&#x80ba;&#x529f;&#x80fd;&#x8870;&#x7aed;&#x524d;&#x671f;&#xff09;&#x75c5;&#x4f8b;99&#x4f8b;&#x3001;4&#x671f;&#xff08;&#x5fc3;&#x80ba;&#x529f;&#x80fd;&#x8870;&#x7aed;&#x671f;&#xff09;&#x75c5;&#x4f8b;16&#x4f8b;&#xff0c;&#x5206;&#x522b;&#x5360;&#x91cd;&#x75c7;&#x75c5;&#x4f8b;&#x6570;&#x7684;82.5<i>%</i>&#xff08;95<i>%CI</i>&#xff1a;79.4<i>%</i>~85.3<i>%</i>&#xff09;&#x3001;15.1<i>%</i>&#xff08;95<i>%CI</i>&#xff1a;12.4<i>%</i>~18.0<i>%</i>&#xff09;&#x3001;2.4<i>%</i>&#xff08;95<i>%CI</i>&#xff1a;1.4<i>%</i>~3.9<i>%</i>&#xff09;&#x3002;11&#x4f8b;&#x6709;&#x540e;&#x9057;&#x75c7;&#xff0c;&#x5360;&#x91cd;&#x75c7;&#x75c5;&#x4f8b;&#x6570;&#x7684;1.7<i>%</i>&#xff08;95<i>%CI</i>&#xff1a;0.9<i>%</i>~3.0<i>%</i>&#xff09;&#xff1b;8&#x4f8b;&#x6b7b;&#x4ea1;&#xff0c;&#x75c5;&#x6b7b;&#x7387;&#x4e3a;1.2<i>%</i>&#xff08;95<i>%CI</i>&#xff1a;0.6<i>%</i>~2.3<i>%</i>&#xff09;&#x3002;&#x4e34;&#x5e8a;2&#x3001;3&#x548c;4&#x671f;&#x5728;&#x5404;&#x5e74;&#x9f84;&#x7ec4;&#x3001;5&#x4e2a;&#x7701;&#x4efd;&#x3001;&#x540e;&#x9057;&#x75c7;&#x75c5;&#x4f8b;&#x6570;&#x3001;&#x6b7b;&#x4ea1;&#x4f8b;&#x6570;&#x7684;&#x6784;&#x6210;&#x6bd4;&#x5dee;&#x5f02;&#x5747;&#x6709;&#x7edf;&#x8ba1;&#x5b66;&#x610f;&#x4e49;&#xff08;&#x5206;&#x522b;&#x4e3a;<i>&#x3c7;</i>(2)=22.632&#xff0c;<i>P</i>=0.012&#xff1b;<i>&#x3c7;</i>(2)=41.481&#xff0c;<i>P</i>=0.000&#xff1b;<i>&#x3c7;</i>(2)=12.960&#xff0c;<i>P</i>=0.001&#xff1b;<i>&#x3c7;</i>(2)=16.850&#xff0c;<i>P</i>=0.001&#xff09;&#x3002; <b>&#x7ed3;&#x8bba;&#xff1a;</b> &#x624b;&#x8db3;&#x53e3;&#x75c5;&#x91cd;&#x75c7;&#x75c5;&#x4f8b;&#x4e34;&#x5e8a;&#x5206;&#x671f;&#x4e0e;&#x540e;&#x9057;&#x75c7;&#x3001;&#x6b7b;&#x4ea1;&#x7ed3;&#x5c40;&#x6709;&#x5173;&#x8054;&#x6027;&#x3002;&#x4e34;&#x5e8a;&#x5206;&#x671f;&#x53ef;&#x7528;&#x4e8e;&#x624b;&#x8db3;&#x53e3;&#x75c5;&#x91cd;&#x75c7;&#x75c5;&#x4f8b;&#x4e25;&#x91cd;&#x7a0b;&#x5ea6;&#x7684;&#x8bc4;&#x4ef7;&#x3002;.</AbstractText></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Clinical outcome</Keyword><Keyword MajorTopicYN="N">Clinical stage</Keyword><Keyword MajorTopicYN="N">Hand, foot and mouth disease</Keyword><Keyword MajorTopicYN="N">Severe case</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>6</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>6</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>9</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28651405</ArticleId><ArticleId IdType="doi">10.3760/cma.j.issn.0254-6450.2017.05.019</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>